Retraction

Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population

Paper Information

Record ID:
32861
Author(s):
Shubo Tan
Yongmao Zeng
Shiliang Kuang
Jianjun Li
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy ( Taylor and Francis - Dove Press )
Publication Date:
April 16, 2021
Retraction Date:
October 06, 2021 (4.1 years years ago)
Subjects:
Broad Categories:
Medicine Biology Biochemistry
Institution:
Department of Urology, Second Affiliated Hospital of the University of South China, Hengyang City, 421000, People’s Republic of China
Country:
🇨🇳 China
Article Type:
Research Article
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
10.2147/DMSO.S300940
PubMed ID:
33889001
Retraction PubMed ID:
34675569

Retraction Details

Retraction Reason:

Lack of IRB/IACUC Approval and/or Compliance

Nature of Retraction:

Retraction

Retraction Notice:
10.2147/DMSO.S342648

Citations (0)

0
Total Citations
0
Post-Retraction
0
Pre-Retraction
0
Same Day
No citations found for this paper.
Quick Stats
Total Citations: 0
Years Since Retraction: 4.1 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Metal ion-directed assembly of two mixed-ligand coordinatio…
Inorganic and Nano-Metal Chemistry • 0 citations
Correlation and Diagnostic Value of Serum Cys-C, RBP4, and …
Evidence-Based Complementary and Alternative Medicine • 14 citations
Genetic variants linked to T2DM risk in Kurdish populations
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy • 2 citations
Randomized, Double-blind, Placebo-controlled, Linear Dose, …
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy • 60 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice